BioCentury
ARTICLE | Company News

Norwood Immunology, Bestewil Holding BV deal

January 30, 2006 8:00 AM UTC

NIM received an option to acquire Bestewil for up to E25 million ($30.3 million), including E20 million ($24.2 million) in stock and E5 million ($6.1 million) in cash. Bestewil is the parent company o...